#USA #New York #Securities #Faruqi & Faruqi #Zynex

Zynex Investors Alert: Class Action Deadline Approaching

Zynex, Inc., known for its medical devices, faces scrutiny as Faruqi & Faruqi, LLP initiates an investigation into potential securities violations by the company. Investors who suffered losses while acquiring Zynex securities between February 25, 2021, and December 15, 2025, are urged to evaluate their legal rights ahead of the April 21, 2026 deadline for becoming lead plaintiffs in a federal securities class action.

Understanding the Nature of the Allegations

The class action aims to address serious grievances related to misleading information provided by Zynex’s executives. Allegations assert that the company engaged in practices that artificially inflated its revenue figures. Particular attention has been directed towards claims that Zynex shipped more products than necessary, potentially overstating sales figures significantly.

Troubling reports have emerged claiming that the firm neglected compliance with industry standards while pursuing aggressive sales tactics. These issues drew scrutiny from insurers, including Tricare, who subsequently temporarily suspended payments due to concerns over potentially fraudulent billing practices. The firm has come under fire not only from investors but also from entities alleging fraudulent claims submission with demands for significant compensatory damages.

Recent Events and Market Reaction

On March 11, 2025, Zynex disclosed shocking financial results detailing a substantial revenue shortfall during the fourth quarter of 2024, which correlated with delayed payments from various insurers. Zynex admitted that one of its largest clients, Tricare, had put a hold on payments pending a review of prior claims. This disclosure resulted in a staggering loss as the stock price plummeted by over 51% the following day.

Subsequent revelations in July 2025 indicated that Zynex had been non-compliant with regulations, leading to a leadership overhaul and further stock price decline. These events demonstrate a concerning trend of operational missteps that have compounded investor losses, amplifying the need for legal recourse.

Opportunity for Investors to Act

Investors impacted by Zynex's actions have an opportunity to take part in the ongoing legal proceedings. Those who wish to act as lead plaintiffs must meet specific criteria established by the court. They would need to demonstrate adequate financial stakes and typicality amongst class members. Interested individuals may reach out to Faruqi & Faruqi directly for more information.

Additionally, the firm is actively seeking any individuals who may have information regarding Zynex’s practices, including whistleblowers and former employees. This outreach indicates that there may still be unknown facets of the case that could enrich the allegations against the company.

For more insights and updates on the situation, investors can visit Faruqi & Faruqi’s official website or contact Senior Partner Josh Wilson directly. He emphasizes the importance of collective action in seeking justice for investors affected by Zynex's alleged misconduct.

\[Faruqi & Faruqi LLC has built a reputation for representing investors and securing recoveries totaling hundreds of millions since its inception in 1995. Its proactive approach in investigating and addressing corporate misdeeds has made it a notable player in securities law practices.\]

Investors should maintain vigilance and stay informed as the situation unfolds. Without doubt, the forthcoming months leading up to the class action deadline will be crucial for Zynex investors wishing to reclaim their footing amidst significant financial challenges.